GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Hans Biomed Corp (XKRX:042520) » Definitions » EBITDA Margin %

Hans Biomed (XKRX:042520) EBITDA Margin % : 4.99% (As of Dec. 2024)


View and export this data going back to 2009. Start your Free Trial

What is Hans Biomed EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Hans Biomed's EBITDA for the three months ended in Dec. 2024 was ₩991 Mil. Hans Biomed's Revenue for the three months ended in Dec. 2024 was ₩19,876 Mil. Therefore, Hans Biomed's EBITDA margin for the quarter that ended in Dec. 2024 was 4.99%.


Hans Biomed EBITDA Margin % Historical Data

The historical data trend for Hans Biomed's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hans Biomed EBITDA Margin % Chart

Hans Biomed Annual Data
Trend Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -14.63 -22.56 19.72 -16.42 0.65

Hans Biomed Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.33 7.28 8.35 -18.34 4.99

Competitive Comparison of Hans Biomed's EBITDA Margin %

For the Medical Devices subindustry, Hans Biomed's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hans Biomed's EBITDA Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Hans Biomed's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Hans Biomed's EBITDA Margin % falls into.


;
;

Hans Biomed EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Hans Biomed's EBITDA Margin % for the fiscal year that ended in Sep. 2024 is calculated as

EBITDA Margin %=EBITDA (A: Sep. 2024 )/Revenue (A: Sep. 2024 )
=530.355/81137.434
=0.65 %

Hans Biomed's EBITDA Margin % for the quarter that ended in Dec. 2024 is calculated as

EBITDA Margin %=EBITDA (Q: Dec. 2024 )/Revenue (Q: Dec. 2024 )
=991.214/19876.134
=4.99 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hans Biomed  (XKRX:042520) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Hans Biomed EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Hans Biomed's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Hans Biomed Business Description

Traded in Other Exchanges
N/A
Address
No.7, Jeong-i-ro 8-gil, Songpa-gu, Seoul, KOR
Hans Biomed Corp manufactures and markets bioengineering products. The company manufactures and sells skin and bone grafts for human transplantation, medical devices, silicone products, etc.

Hans Biomed Headlines

No Headlines